What is HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is a mathematical formula used to estimate insulin resistance from fasting blood glucose and insulin levels, calculated as the product of fasting glucose and insulin, divided by 22.5, serving as a surrogate for insulin resistance in non-diabetic persons 1. The formula provides a simple and non-invasive way to assess insulin function, which is valuable because insulin resistance often precedes the development of type 2 diabetes and is associated with metabolic syndrome, cardiovascular disease, and other health conditions. Some key points to consider when using HOMA-IR include:

  • The calculation is performed by multiplying fasting insulin (in mU/ml) by fasting glucose (in mmol/L) and dividing by 22.5 1.
  • The validity of HOMA-IR depends on the ability of insulin secretion to adapt to insulin resistance, which may limit its suitability in overt diabetes 1.
  • There is no agreement on a threshold defining insulin resistance using HOMA-IR, and the assays for insulin measurements can vary widely 1.
  • Liver disease progression has been associated with persistence or worsening of metabolic abnormalities, including HOMA-IR 1. The use of HOMA-IR can help clinicians identify individuals at risk of developing type 2 diabetes and other health conditions, allowing for early intervention and prevention strategies.

From the Research

Definition of HOMA-IR

  • HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is a method for assessing beta-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations 2.
  • It is a key laboratory index in the assessment of insulin resistance, which is a major global public health problem 3.

Calculation and Estimation of HOMA-IR

  • The calculation of HOMA-IR is partly based on plasma glucose determinations, which are prone to important pre-analytical errors 3.
  • Glycated hemoglobin (Hb) fractions can be used as an alternative for fasting glucose in calculating HOMA-IR, as they strongly correlate with fasting glucose levels and are more stable analytes 3.
  • HOMA-IR can be estimated using a mathematical model, which takes into account fasting insulin and glucose levels 4.

Clinical Applications of HOMA-IR

  • HOMA-IR is a simple and useful method for evaluating insulin sensitivity in patients with type 2 diabetes, including those on insulin therapy 5.
  • It can be used to assess the effectiveness of antidiabetic therapeutic regimens on insulin resistance and beta-cell activity 4.
  • HOMA-IR cut-offs for identifying metabolic syndrome might vary across populations and body mass index (BMI) levels, and the use of cut-off points according to ROC curve may be the better strategy 6.

Advantages and Limitations of HOMA-IR

  • HOMA-IR has the advantage of requiring only a single plasma sample assayed for insulin and glucose, making it a less invasive and less labor-intensive method than other tests 2.
  • However, the primary input data need to be robust, and the data need to be interpreted carefully, as with all models 2.
  • HOMA-IR has been validated against a variety of physiological methods, and it compares favorably with other models 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.